
| Salt Composition: | Glimepiride (1mg) + Metformin (500mg) + Pioglitazone (5mg) |
| Manufacturer: | SAG Health Science Pvt Ltd |
| Storage: | Below 25 degree celcius |
Out of Stock
Have doubts about this medicine?
Have doubts about this medicine?
Glimseg-P1 Tablet SR is a combination medicine that helps control blood sugar levels in adults with type 2 diabetes mellitus. Glimseg-P1 Tablet SR is a combination medicine that helps control blood sugar levels. This medicine is used together with diet and exercise to improve blood sugar control in adults with type 2 diabetes mellitus. It helps in proper utilisation of insulin, thereby lowering the blood sugar levels.
Glimseg-P1 Tablet SR is a combination of three antidiabetic medicines: Glimepiride, Metformin and Pioglitazone.They work by different mechanisms to provide better control of blood sugar when single or dual therapy is not effective.Glimepiride is a sulfonylurea which works by increasing the amount of insulin released by the pancreas in order to lower the blood glucose.Metformin is a biguanide which works by lowering glucose production in the liver, delaying glucose absorption from intestines and increasing the body's sensitivity to insulin.Pioglitazone is a thiazolidinedione which further increases insulin sensitivity
Take this medicine in the dose and duration as advised by your doctor.Swallow it as a whole.Do not chew, crush or break it.Take it with food
Alcohol
It is unsafe to consume alcohol with Glimseg-P1 Tablet SR.
Breastfeed
Glimseg-P1 Tablet SR is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Pregnancy
Glimseg-P1 Tablet SR may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby.